Deep Medicine: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Deep Medicine
Largest movements
- Cash -€16,257
down €16,257 (-84.6%), from €19,222 to €2,965
mainly Debts after one year (-€53,578) and Net result for the year (-€27,919)
- Intangible fixed assets -€2,925
down €2,925 (-1.6%), from €177,716 to €174,791
- Debts after one year -€53,578
down €53,578 (-61.1%), from €87,621 to €34,042
- Other debts +€52,044
up €52,044 (+38.2%), from €136,295 to €188,339
- Profit (loss) carried forward -€27,919
down €27,919 (-68.8%), from -€40,609 to -€68,528
- Trade debts +€12,852
up €12,852 (+529%), from €2,429 to €15,281
- Tax, wage and social debts -€2,475
no longer reported in 2025 (was €2,475)
- Depreciation -€49,855
down €49,855 (-94.5%), from €52,780 to €2,925
- Gross operating margin -€30,013
down €30,013, from €6,388 to -€23,625
- Other operating charges -€2,201
down €2,201 (-94.8%), from €2,321 to €120
- Financial charges -€602
down €602 (-32.3%), from €1,862 to €1,261
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €196,946 | €177,869 | -€19,078 | -9.7% |
| Fixed assets | 21/28 | €177,716 | €174,791 | -€2,925 | -1.6% |
| Intangible fixed assets | 21 | €177,716 | €174,791 | -€2,925 | -1.6% |
| Current assets | 29/58 | €19,231 | €3,078 | -€16,153 | -84.0% |
| Amounts receivable within one year | 40/41 | €8 | €113 | +€104 | +1,239% |
| Other amounts receivable | 41 | €8 | €113 | +€104 | +1,239% |
| Cash at bank and in hand | 54/58 | €19,222 | €2,965 | -€16,257 | -84.6% |
| Total equity and liabilities | 10/49 | €196,946 | €177,869 | -€19,078 | -9.7% |
| Equity | 10/15 | -€31,911 | -€59,830 | -€27,919 | -87.5% |
| Contributions | 10/11 | €7,907 | €7,907 | = | 0.0% |
| Reserves | 13 | €791 | €791 | = | 0.0% |
| Non-distributable reserves | 130/1 | €791 | €791 | = | 0.0% |
| Reserves not available under the articles | 1311 | €791 | €791 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€40,609 | -€68,528 | -€27,919 | -68.8% |
| Amounts payable | 17/49 | €228,857 | €237,699 | +€8,842 | +3.9% |
| Amounts payable after more than one year | 17 | €87,621 | €34,042 | -€53,578 | -61.1% |
| Financial debts | 170/4 | €87,621 | €34,042 | -€53,578 | -61.1% |
| Amounts payable within one year | 42/48 | €141,237 | €203,657 | +€62,420 | +44.2% |
| Financial debts | 43 | €38 | €37 | -€1 | -3.0% |
| Credit institutions | 430/8 | €38 | €37 | -€1 | -3.0% |
| Trade debts | 44 | €2,429 | €15,281 | +€12,852 | +529% |
| Suppliers | 440/4 | €2,429 | €15,281 | +€12,852 | +529% |
| Taxes, remuneration and social security | 45 | €2,475 | - | -€2,475 | |
| Taxes | 450/3 | €2,475 | - | -€2,475 | |
| Other amounts payable | 47/48 | €136,295 | €188,339 | +€52,044 | +38.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €52,780 | €2,925 | -€49,855 | -94.5% |
| Other operating charges | 640/8 | €2,321 | €120 | -€2,201 | -94.8% |
| Gross operating margin | 9900 | €6,388 | -€23,625 | -€30,013 | |
| Operating profit (loss) | 9901 | -€48,712 | -€26,670 | +€22,043 | +45.3% |
| Financial income | 75/76B | €10 | €11 | +€1 | +12.0% |
| Recurring financial income | 75 | €10 | €11 | +€1 | +12.0% |
| Financial charges | 65/66B | €1,862 | €1,261 | -€602 | -32.3% |
| Recurring financial charges | 65 | €1,862 | €1,261 | -€602 | -32.3% |
| Profit (loss) for the period before taxes | 9903 | -€50,565 | -€27,919 | +€22,645 | +44.8% |
| Profit (loss) for the period | 9904 | -€50,565 | -€27,919 | +€22,645 | +44.8% |
| Profit (loss) for the period to be appropriated | 9905 | -€50,565 | -€27,919 | +€22,645 | +44.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.